Health
GSK says long-acting HIV prevention drug 66% more effective than Truvada – WHTC News
(Reuters) – Britain’s GSK said on Tuesday that an injection of its cabotegravir drug given every two months was found to be 66% more effective in preventing HIV infections than Gilead’s Truvada daily oral pills.
HIV incidence rate – or the number of people wh…
(Reuters) – Britain’s GSK said on Tuesday that an injection of its cabotegravir drug given every two months was found to be 66% more effective in preventing HIV infections than Gilead’s Truvada daily…
-
General22 hours agoTrump hails US, UK’s ‘unbreakable bond’ at talks
-
General18 hours agoClashes and disruption in France amid nationwide protests over Emmanuel Macron’s austerity policies
-
Noosa News11 hours agoGippsland farmer blocks AusNet maintenance workers from entering property
-
General24 hours agoPope Leo talks Trump, sex abuse scandals, welcoming the LGBTQ+ community and China in his first interview